# Help Content Functions
# Contextual help panels for each analysis type

#' Create contextual help accordion for a specific analysis
#' @param analysis_type The type of analysis (e.g., "single_proportion", "two_group")
#' @return A bslib accordion component with contextual help
create_contextual_help <- function(analysis_type) {
  
  help_content <- switch(analysis_type,
    
    # ============================================================
    # SINGLE PROPORTION
    # ============================================================
    "single_proportion" = accordion(
      id = paste0("help_", analysis_type),
      open = FALSE,
      accordion_panel(
        title = "About this Analysis",
        icon = icon("info-circle"),
        p("The 'Rule of Three' states that if a certain event did not occur in a sample with n participants, the interval from 0 to 3/n is a 95% confidence interval for the rate of occurrences in the population. When n is greater than 30, this is a good approximation."),
        p(strong("Example:"), "If a drug is tested on 1,500 participants and no adverse event is recorded, we can conclude with 95% confidence that fewer than 1 person in 500 (or 3/1500 = 0.2%) will experience an adverse event.")
      ),
      accordion_panel(
        title = "Use Cases",
        icon = icon("lightbulb"),
        tags$ul(
          tags$li("Post-marketing surveillance of pharmaceutical products"),
          tags$li("Rare adverse event detection in safety studies"),
          tags$li("Quality control and manufacturing safety"),
          tags$li("Clinical trial safety monitoring")
        )
      ),
      accordion_panel(
        title = "References",
        icon = icon("book"),
        tags$ul(
          tags$li(a("Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA. 1983;249(13):1743-1745.", 
                    href = "Hanley-1983-1743.pdf", target = "_blank")),
          tags$li("Eypasch E, et al. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ. 1995;311(7005):619-620.")
        )
      )
    ),
    
    # ============================================================
    # TWO-GROUP COMPARISONS
    # ============================================================
    "two_group" = accordion(
      id = paste0("help_", analysis_type),
      open = FALSE,
      accordion_panel(
        title = "About this Analysis",
        icon = icon("users"),
        p("Two-group comparison tests whether event rates differ between two independent groups (e.g., exposed vs. unexposed, treatment vs. control). This is fundamental for comparative effectiveness research and observational studies."),
        p(strong("Example:"), "Comparing hospitalization rates between patients prescribed Drug A vs. Drug B using claims data.")
      ),
      accordion_panel(
        title = "Study Designs & Use Cases",
        icon = icon("lightbulb"),
        tags$ul(
          tags$li(strong("Cohort studies:"), "Prospective or retrospective comparison of outcomes between exposure groups"),
          tags$li(strong("Comparative effectiveness studies:"), "Real-world comparison of treatment options"),
          tags$li(strong("RCTs:"), "Randomized controlled trials comparing interventions"),
          tags$li(strong("Database studies:"), "Claims, EHR, or registry-based comparisons")
        )
      ),
      accordion_panel(
        title = "Effect Measures",
        icon = icon("calculator"),
        p("The tool calculates three key effect measures:"),
        tags$ul(
          tags$li(strong("Risk Difference (RD):"), "Absolute difference in event rates (Group 1 - Group 2)"),
          tags$li(strong("Relative Risk (RR):"), "Risk ratio (P1/P2). RR > 1 indicates increased risk in Group 1"),
          tags$li(strong("Odds Ratio (OR):"), "Odds ratio. Approximates RR when events are rare (<10%)")
        )
      ),
      accordion_panel(
        title = "References",
        icon = icon("book"),
        tags$ul(
          tags$li("Fleiss JL, Levin B, Paik MC. Statistical Methods for Rates and Proportions. 3rd ed. Wiley; 2003."),
          tags$li("Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005;365(9467):1348-1353.")
        )
      )
    ),
    
    # ============================================================
    # SURVIVAL ANALYSIS
    # ============================================================
    "survival" = accordion(
      id = paste0("help_", analysis_type),
      open = FALSE,
      accordion_panel(
        title = "About this Analysis",
        icon = icon("chart-line"),
        p("Survival analysis is used for time-to-event outcomes, which are extremely common in pharmaceutical RWE studies (e.g., time to hospitalization, time to disease progression, time to death)."),
        p(strong("Method:"), "Uses the Schoenfeld (1983) method for Cox proportional hazards regression, implemented in the powerSurvEpi R package."),
        p(strong("Example:"), "Estimating sample size to detect a 30% reduction in risk of cardiovascular events (HR = 0.7) in a cohort study.")
      ),
      accordion_panel(
        title = "Key Inputs Explained",
        icon = icon("question-circle"),
        tags$ul(
          tags$li(strong("Hazard Ratio (HR):"), "Expected ratio of hazard rates between groups. HR < 1 indicates protective effect, HR > 1 indicates increased risk."),
          tags$li(strong("Proportion Exposed:"), "Proportion of the cohort in the exposed/treatment group."),
          tags$li(strong("Overall Event Rate:"), "Expected proportion experiencing the event during follow-up across all participants."),
          tags$li(strong("Significance Level (Î±):"), "Type I error rate, typically 0.05.")
        )
      ),
      accordion_panel(
        title = "Use Cases",
        icon = icon("lightbulb"),
        tags$ul(
          tags$li("Time to cardiovascular events (MI, stroke, death)"),
          tags$li("Time to disease progression or recurrence"),
          tags$li("Time to treatment discontinuation"),
          tags$li("Time to hospitalization or ER visit"),
          tags$li("Overall survival in oncology studies")
        )
      ),
      accordion_panel(
        title = "References",
        icon = icon("book"),
        tags$ul(
          tags$li("Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39(2):499-503."),
          tags$li("Collett D. Modelling Survival Data in Medical Research. 3rd ed. Chapman & Hall/CRC; 2014.")
        )
      )
    ),
    
    # ============================================================
    # MATCHED CASE-CONTROL
    # ============================================================
    "matched" = accordion(
      id = paste0("help_", analysis_type),
      open = FALSE,
      accordion_panel(
        title = "About this Analysis",
        icon = icon("link"),
        p("Matched case-control studies use matching strategies to control for confounding, such as propensity score matching or traditional matching on demographic and clinical characteristics."),
        p(strong("Example:"), "Matched case-control study examining association between statin use and liver injury, matching on age, sex, and diabetes status.")
      ),
      accordion_panel(
        title = "When to Use Matching",
        icon = icon("question-circle"),
        tags$ul(
          tags$li("When cases and controls need to be balanced on important confounders"),
          tags$li("When you have more potential controls than cases"),
          tags$li("When matching on factors like age, sex, comorbidities, enrollment date"),
          tags$li("When using propensity score matching in observational studies")
        )
      ),
      accordion_panel(
        title = "Matching Ratios",
        icon = icon("calculator"),
        p("This tool supports various matching ratios:"),
        tags$ul(
          tags$li(strong("1:1 matching:"), "One control per case (most common)"),
          tags$li(strong("2:1 matching:"), "Two controls per case (more efficient)"),
          tags$li(strong("3:1 matching:"), "Three controls per case"),
          tags$li(strong("Higher ratios:"), "Diminishing returns after 4:1")
        ),
        p("Higher matching ratios increase power but require more controls.")
      ),
      accordion_panel(
        title = "References",
        icon = icon("book"),
        tags$ul(
          tags$li("Dupont WD. Power calculations for matched case-control studies. Biometrics. 1988;44(4):1157-1168."),
          tags$li("Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume 1: The Analysis of Case-Control Studies. IARC; 1980.")
        )
      )
    ),
    
    # ============================================================
    # CONTINUOUS OUTCOMES
    # ============================================================
    "continuous" = accordion(
      id = paste0("help_", analysis_type),
      open = FALSE,
      accordion_panel(
        title = "About this Analysis",
        icon = icon("calculator"),
        p("Power and sample size calculations for comparing continuous endpoints between two groups using two-sample t-tests. Assumes approximately normal distributions or large enough samples for Central Limit Theorem."),
        p(strong("Example:"), "Comparing mean HbA1c reduction between two diabetes medications in an RWE study using EHR data.")
      ),
      accordion_panel(
        title = "Use Cases",
        icon = icon("lightbulb"),
        tags$ul(
          tags$li(strong("Lab values:"), "HbA1c, cholesterol, blood pressure, biomarkers"),
          tags$li(strong("Physical measures:"), "BMI, weight change, bone density"),
          tags$li(strong("Patient-reported outcomes:"), "Quality of life scores, pain scales"),
          tags$li(strong("Cognitive tests:"), "Memory scores, functional assessments"),
          tags$li(strong("Healthcare utilization:"), "Number of visits, costs")
        )
      ),
      accordion_panel(
        title = "Understanding Effect Size (Cohen's d)",
        icon = icon("question-circle"),
        p("Effect size (Cohen's d) is the standardized mean difference:"),
        p(strong("Formula:"), "d = (Meanâ - Meanâ) / Pooled SD"),
        p(strong("Conventional benchmarks:")),
        tags$ul(
          tags$li(strong("Small:"), "d = 0.2 (subtle difference)"),
          tags$li(strong("Medium:"), "d = 0.5 (moderate difference)"),
          tags$li(strong("Large:"), "d = 0.8 (substantial difference)")
        ),
        p("However, clinical significance should guide interpretation, not just statistical benchmarks.")
      ),
      accordion_panel(
        title = "References",
        icon = icon("book"),
        tags$ul(
          tags$li("Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Routledge; 1988."),
          tags$li("Lakens D. Calculating and reporting effect sizes to facilitate cumulative science. Front Psychol. 2013;4:863.")
        )
      )
    ),
    
    # ============================================================
    # NON-INFERIORITY
    # ============================================================
    "noninferiority" = accordion(
      id = paste0("help_", analysis_type),
      open = FALSE,
      accordion_panel(
        title = "About this Analysis",
        icon = icon("balance-scale"),
        p("Non-inferiority trials aim to demonstrate that a new treatment is 'not worse' than a reference treatment by more than a pre-specified margin. This is common in generic drug approval, biosimilar studies, and situations where superiority is not expected or ethical."),
        p(strong("Example:"), "Demonstrating a generic formulation has adverse event rates no worse than branded drug +5 percentage points.")
      ),
      accordion_panel(
        title = "Non-Inferiority Margin",
        icon = icon("ruler"),
        p("The non-inferiority margin is the maximum clinically acceptable difference in outcomes."),
        tags$ul(
          tags$li(strong("Clinical judgment:"), "Should be based on what difference would be clinically meaningful"),
          tags$li(strong("Regulatory guidance:"), "FDA/EMA require pre-specification with justification"),
          tags$li(strong("Historical data:"), "Typically smaller than the expected treatment effect of the reference"),
          tags$li(strong("Common practice:"), "Margin should preserve a substantial portion of reference treatment's effect")
        )
      ),
      accordion_panel(
        title = "Regulatory Context",
        icon = icon("gavel"),
        tags$ul(
          tags$li(strong("FDA/EMA requirement:"), "Pre-specification of non-inferiority margin with clinical justification"),
          tags$li(strong("Statistical significance:"), "One-sided Î± = 0.025 (equivalent to two-sided Î± = 0.05) is standard"),
          tags$li(strong("Confidence interval:"), "Upper bound of 95% CI must fall below the margin"),
          tags$li(strong("ITT analysis:"), "Intent-to-treat is conservative for non-inferiority; per-protocol often also required")
        )
      ),
      accordion_panel(
        title = "References",
        icon = icon("book"),
        tags$ul(
          tags$li(a("FDA Guidance: Non-Inferiority Clinical Trials to Establish Effectiveness",
                    href = "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/non-inferiority-clinical-trials-establish-effectiveness",
                    target = "_blank")),
          tags$li("Piaggio G, et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-2604.")
        )
      )
    ),
    
    # Default fallback
    NULL
  )
  
  return(help_content)
}

#' Create global help content (Regulatory Guidance & Interpretation Guide)
#' To be used in a Help modal or separate page
create_global_help <- function() {
  accordion(
    id = "global_help_accordion",
    open = FALSE,
    accordion_panel(
      title = "Regulatory Guidance & References",
      icon = icon("book"),
      h5("FDA/EMA Guidance on RWE"),
      tags$ul(
        tags$li(a("FDA - Real-World Evidence Framework",
          href = "https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence",
          target = "_blank"
        )),
        tags$li(a("FDA - Use of Real-World Evidence (2023)",
          href = "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-world-data-assessing-electronic-health-records-and-medical-claims-data-support-regulatory",
          target = "_blank"
        )),
        tags$li(a("EMA - Real World Evidence Framework",
          href = "https://www.ema.europa.eu/en/about-us/how-we-work/big-data/real-world-evidence",
          target = "_blank"
        ))
      ),
      h5("Key Statistical References"),
      tags$ul(
        tags$li("Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA. 1983;249(13):1743-1745."),
        tags$li("Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39(2):499-503."),
        tags$li("Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Routledge; 1988."),
        tags$li("Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2(2):93-113.")
      )
    ),
    accordion_panel(
      title = "Interpretation Guide",
      icon = icon("question-circle"),
      h5("Understanding Power"),
      p("Power is the probability of detecting a true effect when it exists. Conventionally:"),
      tags$ul(
        tags$li(strong("80% power:"), "Standard for most studies"),
        tags$li(strong("90% power:"), "Preferred for pivotal or confirmatory studies"),
        tags$li(strong("<70% power:"), "Generally considered inadequate")
      ),
      h5("Understanding Significance Level (Î±)"),
      tags$ul(
        tags$li(strong("Î± = 0.05:"), "Standard for most studies (5% false positive rate)"),
        tags$li(strong("Î± = 0.01:"), "More conservative, used for multiple testing or critical decisions"),
        tags$li(strong("Î± = 0.10:"), "Sometimes used in exploratory studies")
      ),
      h5("Effect Sizes"),
      tags$ul(
        tags$li(strong("Hazard Ratio (HR):"), "HR < 1 = protective, HR > 1 = increased risk, HR = 1 = no effect"),
        tags$li(strong("Odds Ratio (OR):"), "Similar interpretation to HR for rare outcomes"),
        tags$li(strong("Relative Risk (RR):"), "More intuitive than OR; directly interpretable as relative increase/decrease in risk")
      )
    )
  )
}

